Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
Anemia, Sickle Cell (Phase 2)
Trials (1 total)
Trial APIs (1 total)